Fulgent Genetics (FLGT) Retained Earnings (2015 - 2026)

Fulgent Genetics has disclosed Retained Earnings across 12 years of filings, most recently posting $475.6 million for Q2 2026.

• In Q2 2026, Retained Earnings fell 15.07% year-over-year to $475.6 million; the TTM figure through Jun 2026 stood at $475.6 million (down 15.07% YoY), while the FY2025 annual figure was $530.0 million, down 10.25% from the prior year.
• Retained Earnings came in at $475.6 million for Q2 2026 at Fulgent Genetics, down from $505.1 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $824.8 million in Q3 2022 to a low of $475.6 million in Q2 2026.
• Average Retained Earnings over 5 years is $657.5 million, with a median of $615.4 million recorded in 2024.
• Year-over-year, Retained Earnings soared 131.27% in 2022 and slipped 21.67% in 2024.
• Over 5 years, Retained Earnings stood at $801.0 million in 2022, then retreated by 20.95% to $633.2 million in 2023, then declined by 6.75% to $590.5 million in 2024, then slipped by 10.25% to $530.0 million in 2025, then retreated by 10.26% to $475.6 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $475.6 million in Q2 2026, $505.1 million in Q1 2026, and $530.0 million in Q4 2025.